|
|
LISTEN NOW: OUR LATEST PODCAST EPISODES |
|
|
|
| Check out the latest episodes from Cell & Gene: The Podcast and Business of Biotech. As a member of the Life Science Connect community, you have access to content beyond our weekly newsletters, including our podcast series. |
|
|
THE PODCAST FOR LEADERS OF EMERGING BIOPHARMA |
|
|
|
|
| BoB@JPM: Rick Modi, Affinia Therapeutics | The latest in our series of Business of Biotech podcasts, recorded in-person at JPM in San Francisco, features an inspiring conversation with Affinia Therapeutics CEO Rick Modi, who shares how his upbringing shaped his adversity-embracing worldview. |
|
|
| BoB@JPM: Kasper Roet, Ph.D., QurAlis | On this episode, Life Science Leader's Ben Comer joins to co-host a conversation with Dr. Roet that goes deep on his company's genetic medicine approach to ALS, and even deeper into his opinions on, and growing influence over, the regulatory environment. |
|
|
| BoB@JPM: Nima Farzan, Latigo Biotherapeutics | In this final installment of our episodes recorded and filmed on-site at the JP Morgan Healthcare Conference, Nima Farzan, CEO of Latigo Biotherapeutics, shares his company's mission to change the pain management paradigm by way of novel, non-opioid medications that target NAV 1.8 sodium channels involved in pain signal transmission. |
|
|
| Business of Biotech 2.0 With Ben Comer | After nearly five years as host of the Business of Biotech podcast, Matt Pillar is handing the mic over to the voice of the Business of Biotech 2.0, veteran life sciences journalist Ben Comer. |
|
|
VOICES FROM THE FRONT LINE OF CELL AND GENE DISCOVERY |
|
|
|
|
|
|
